pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,346 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 16 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,346
  • earnings286
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›WITHDRAWNphase readoutNCT06726707: COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis

    Sponsor: Hospital Israelita Albert Einstein. Phase: PHASE2. Conditions: Incontinence-associated Dermatitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06118892: MISHA Post-Market Clinical Study

    Sponsor: Moximed. Phase: NA. Conditions: Osteo Arthritis Knee

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05303792: Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

    Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE2. Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334236: Energy Ramping Versus Fixed Dose ESWL

    Sponsor: mohammed Abdelhafez. Phase: NA. Conditions: Renal Calculi

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05675436: Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Sickle Cell Anemia, Sickle Cell Thalassemia, Sickle Cell Pain, Hbss, Hbsc, Sickle Beta Thalassemia, Sickle Beta Zero Thalassemia, Sickle Cell Syndrome Variant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07366671: SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation

    Sponsor: dr Pim A.L. Tonino. Phase: . Conditions: TAVI(Transcatheter Aortic Valve Implantation), Aortic Valve Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06408519: Open-Label Placebo for Non-Specific Pain in the ED

    Sponsor: Bruno Minotti. Phase: NA. Conditions: Pain, Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04907565: Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Obesity, Cognitive Impairment, Post-Operative Confusion

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06283667: Special Use - Results Surveillance on Long-term Use With Wegovy®

    Sponsor: Novo Nordisk A/S. Phase: . Conditions: Obesity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07426900: Effects of Thoracolumbar Stabilization Versus Spinal Decompression Exercises on Maigne's Syndrome

    Sponsor: Riphah International University. Phase: NA. Conditions: Syndrome, Manganese Neurotoxicity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07303400: Assessment of the Effectiveness of a Prototype Diagnostic System of Bacterial Respiratory Infections Based on Real-time Sequencing

    Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Lower Resp Tract Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07513792: The Impact of a 3D Imaging Tool on Reducing Gum Recession During Orthodontic Treatment With Aligners

    Sponsor: University of Liege. Phase: NA. Conditions: Orthodontic, Gingival Recession, Cone-Beam Computed Tomography

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04888936: Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Costello Syndrome, Noonan Syndrome, Cardiofaciocutaneous Syndrome, Legius Syndrome, Capillary Arteriovenous Malformation Syndrome, RASopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05544136: A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Head and Neck Cancer, Head and Neck Carcinoma, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07423611: ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer

    Sponsor: Fudan University. Phase: PHASE2. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04162171: Cohort Study - SBRT for VT Radioablation

    Sponsor: John Sapp. Phase: NA. Conditions: Ventricular Tachycardia, Myocardial Infarction, Heart Disease Structural Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07495371: Passive Static Stretching for Improving Hip Range of Motion in Patients and Healthy Individuals

    Sponsor: Omicron beta research. Phase: . Conditions: Hip Joint Disorders, Recovery After Total Hip Arthroplasty, Healthy Individuals

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07500844: Decontamination Methods in the Treatment of Peri-implantitis

    Sponsor: Research Centre for Medical Genetics, Russian Federation. Phase: NA. Conditions: Peri-implantitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07514767: Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Oral Squamous Cell Carcinoma

    Sponsor: Prof. Lars Olaf Cardell. Phase: PHASE2. Conditions: Oral Squamous Cell Carcinoma (OSCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07569900: A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of iStatis Gonorrhea Antigen Test

    Sponsor: bioLytical Laboratories. Phase: NA. Conditions: Gonorrhea Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06983600: The Effect of SuJok Application on Dysmenorrhea and Quality of Life in Young People With Primary Dysmenorrhea:

    Sponsor: Muş Alparslan University. Phase: NA. Conditions: Dysmenorrhea (Disorder), Alternative Treatment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04355507: Computed Tomography for COVID-19 Diagnosis

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: COVID-19

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03901807: Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study

    Sponsor: Spectral Diagnostics (US) Inc.. Phase: NA. Conditions: Septic Shock, Endotoxemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06571292: Effect of the Dose of Training in Upper Limb Motor Recovery After Stroke.

    Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05526092: OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals

    Sponsor: University of Turku. Phase: NA. Conditions: High Cholesterol/Hyperlipidemia, High Blood Pressure, Overweight and Obesity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04919811: Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC

    Sponsor: Nuvation Bio Inc.. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07324811: Effectiveness of a Home-based Cervical Motor Control Exercise Programme Versus Conventional Manual Therapy in Patients With Post-whiplash Neck Pain.

    Sponsor: Universidad Pontificia de Salamanca. Phase: NA. Conditions: Cervical Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07573007: Epidural Catheter Placement Techniques by Anesthesia Residents: Success and Complications

    Sponsor: Marmara University Pendik Training and Research Hospital. Phase: . Conditions: Epidural Anesthesia, Catheterisation, Education, Postoperative Pain, Medical, Graduate Medical Education

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07389707: The Effect of Using Hand Massage Stimulation Techniques on Pain and Comfort in Pregnant Women Experiencing Lumbar Pain

    Sponsor: Inonu University. Phase: NA. Conditions: Pregnancy Related

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07199192: Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE4. Conditions: Hypoxemia, Severe Acute Respiratory Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06616636: A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07340411: Effect of Chinese Herbal Medicine Nasal Irrigation on the Postoperative Care of Chronic Rhinosinusitis

    Sponsor: Taichung Veterans General Hospital. Phase: PHASE2. Conditions: Chronic Rhinosinusitis, Postoperative Care

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03433911: FemBloc® Permanent Contraception - Early Pivotal Trial

    Sponsor: Femasys Inc.. Phase: NA. Conditions: Contraception

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07349771: Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

    Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Hematopoietic and Lymphatic System Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05495334: Innovations in Genicular Outcomes Registry

    Sponsor: Pacira Pharmaceuticals, Inc. Phase: . Conditions: Knee Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06806592: A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02835911: Clinical Cohort of Lymphoma Patients in Malawi

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: . Conditions: Lymphoma, Hematologic Malignancies

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07054944: Tumor-Lymph Node Mapping

    Sponsor: University of Rochester. Phase: . Conditions: Pediatric Solid Tumors, Rhabdomyosarcoma, Sarcoma, Germ Cell Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07310134: Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors

    Sponsor: Nanjing Zenshine Pharmaceuticals. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05281471: Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

    Sponsor: Genelux Corporation. Phase: PHASE3. Conditions: Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, High-grade Serous Ovarian Cancer, Endometrioid Ovarian Cancer, Ovarian Clear Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07496918: Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)

    Sponsor: Massachusetts Institute of Technology. Phase: PHASE2. Conditions: Cognitively Healthy People, Alzheimer Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05593497: A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

    Sponsor: VA Office of Research and Development. Phase: PHASE2. Conditions: High-Risk Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06510010: Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

    Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: PHASE2. Conditions: Chemotherapy Effect

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07338110: French Achilles Tendon Surgery Cohort Study

    Sponsor: Chirurgie Du Sport. Phase: . Conditions: Achilles Injuries Tendon, Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07348510: Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures

    Sponsor: Cairo University. Phase: NA. Conditions: Diuretic Effect, Aminophylline, Furosemide, Cardiac Surgical Procedures

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06787313: Precision Palliative Care for Patients With Advanced Esophageal Cancer

    Sponsor: Fudan University. Phase: . Conditions: Esophageal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06280924: Prehab Prior to Stem Cell Transplantation in Multiple Myeloma

    Sponsor: University of Alberta. Phase: NA. Conditions: Multiple Myeloma, Exercise, Prehabilitation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07356323: A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery

    Sponsor: Solventum US LLC. Phase: NA. Conditions: Arthroplasty Replacement, Knee, Arthroplasty Total Hip Replacement

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04930159: Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence

    Sponsor: University of Washington. Phase: NA. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07515859: Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

    Sponsor: Yonsei University. Phase: . Conditions: Cancer Therapy-Related Cardiac Dysfunction, Heart Failure, Left Ventricular Dysfunction

    full page →ctgov ↗
    ← prev
    page 24 of 98
    next →